Koyfin Home > Directory > Health Care > Adma Biologics > Total Equity

Adma Biologics Total Equity Chart (ADMA)

Adma Biologics annual/quarterly Total Equity from 2010 to 2020.
  • Adma Biologics Total Equity for the quarter ending June 06, 2020 was $77m a 53.02% increase of 41m year over year
  • Adma Biologics Total Equity for the last 12 months ending June 06, 2020 was $77m a 53.02% increase of 41m year over year
  • Adma Biologics Annual Total Equity for 2019 was $26m a 24.52% increase of 6m from 2018
  • Adma Biologics Annual Total Equity for 2018 was $20m a -104.01% decrease of -21m from 2017
  • Adma Biologics Annual Total Equity for 2017 was $40m a 111.05% increase of 45m from 2016
Other Balance Sheet Metrics:
  • Adma Biologics Total Assets for the quarter ending September 09, 2018 was $106m a -1.57% decrease of -2m year over year
  • Adma Biologics Other Liabilities for the quarter ending December 12, 2018 was $18m a -0.86% decrease of 0m year over year
View Chart On Koyfin

Quarterly ADMA Total Equity Data

06/2020$77m
03/2020$96m
12/2019$26m
09/2019$36m
06/2019$47m
03/2019$10m
12/2018$20m
09/2018$37m
06/2018$52m
03/2018$23m

Annual ADMA Total Equity Data

2019$26m
2018$20m
2017$40m
2016$-4m
2015$1m
2014$6m
2013$22m
2012$9m
2011$0m
2010$-4m